Walleye Capital’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,712
| Closed | -$14K | – | 2319 |
|
|
2024
Q4 | $14K | Buy |
+13,712
| New | +$14K | ﹤0.01% | 1867 |
|
|
2023
Q2 | – | Sell |
-75,699
| Closed | -$133K | – | 2752 |
|
|
2023
Q1 | $133K | Buy |
75,699
+5,893
| +8% | +$10.4K | ﹤0.01% | 1448 |
|
|
2022
Q4 | $219K | Sell |
69,806
-26,009
| -27% | -$81.7K | ﹤0.01% | 1312 |
|
|
2022
Q3 | $469K | Buy |
95,815
+74,747
| +355% | +$366K | 0.01% | 1086 |
|
|
2022
Q2 | $87K | Sell |
21,068
-62,905
| -75% | -$260K | ﹤0.01% | 1725 |
|
|
2022
Q1 | $488K | Buy |
+83,973
| New | +$488K | 0.01% | 989 |
|
|
2021
Q4 | – | Sell |
-11,465
| Closed | -$103 | – | 2234 |
|
|
2021
Q3 | $103 | Buy |
+11,465
| New | +$103 | ﹤0.01% | 1305 |
|
|
2021
Q1 | – | Sell |
-26,700
| Closed | -$417 | – | 1318 |
|
|
2020
Q4 | $417 | Buy |
+26,700
| New | +$417 | 0.03% | 521 |
|
|
2019
Q3 | – | Sell |
-22,699
| Closed | -$244K | – | 928 |
|
|
2019
Q2 | $244K | Buy |
22,699
+21,599
| +1,964% | +$232K | 0.03% | 133 |
|
|
2019
Q1 | $10K | Buy |
+1,100
| New | +$10K | ﹤0.01% | 329 |
|